Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Cash from Investing Activities (2022 - 2025)

Historic Cash from Investing Activities for Prokidney (PROK) over the last 4 years, with Q3 2025 value amounting to $29.0 million.

  • Prokidney's Cash from Investing Activities rose 13554.6% to $29.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $91.0 million, marking a year-over-year increase of 20048.83%. This contributed to the annual value of $20.4 million for FY2024, which is 10618.64% up from last year.
  • Latest data reveals that Prokidney reported Cash from Investing Activities of $29.0 million as of Q3 2025, which was up 13554.6% from $18.6 million recorded in Q2 2025.
  • In the past 5 years, Prokidney's Cash from Investing Activities ranged from a high of $58.4 million in Q1 2024 and a low of -$192.6 million during Q1 2023
  • For the 4-year period, Prokidney's Cash from Investing Activities averaged around -$15.7 million, with its median value being -$306000.0 (2022).
  • Per our database at Business Quant, Prokidney's Cash from Investing Activities tumbled by 3122156.86% in 2023 and then skyrocketed by 31721.28% in 2024.
  • Quarter analysis of 4 years shows Prokidney's Cash from Investing Activities stood at -$306000.0 in 2022, then plummeted by 31221.57% to -$95.8 million in 2023, then surged by 115.73% to $15.1 million in 2024, then skyrocketed by 92.43% to $29.0 million in 2025.
  • Its Cash from Investing Activities was $29.0 million in Q3 2025, compared to $18.6 million in Q2 2025 and $28.3 million in Q1 2025.